Search Results - "Vanessa Petry"

Computational studies of polyurethanases from Pseudomonas by do Canto, Vanessa Petry, Thompson, Claudia Elizabeth, Netz, Paulo Augusto

“…Polyurethanes (PU) are multifunctional polymers, used in automotive industry, in coatings, rigid and flexible foams, and also in biomimetic materials. In the…”
Get full text

Return to work after breast cancer diagnosis: An observational prospective study in Brazil by Landeiro, Luciana C. G., Gagliato, Debora M., Fêde, Angelo B., Fraile, Natalia M., Lopez, Rossana M., da Fonseca, Leonardo G., Petry, Vanessa, Testa, Laura, Hoff, Paulo M., Mano, Max S.

“…Background In North America and Europe, return‐to‐work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36…”
Get full text

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer by Cortés, Javier, Kim, Sung-Bae, Chung, Wei-Pang, Im, Seock-Ah, Park, Yeon Hee, Hegg, Roberto, Kim, Min Hwan, Tseng, Ling-Ming, Petry, Vanessa, Chung, Chi-Feng, Iwata, Hiroji, Hamilton, Erika, Curigliano, Giuseppe, Xu, Binghe, Huang, Chiun-Sheng, Kim, Jee Hyun, Chiu, Joanne W.Y., Pedrini, Jose Luiz, Lee, Caleb, Liu, Yali, Cathcart, Jillian, Bako, Emarjola, Verma, Sunil, Hurvitz, Sara A.

Get full text

A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53) by Petry, Vanessa, Bonadio, Renata Colombo, Testa, Laura, Cohn, Daniela JBH, Cagnacci, Allyne, Campos, Roberta G., Fragoso, Maria Cândida Bv, Estevez-Diz, Maria del Pilar

“…Breast cancer (BC) is the most common type of cancer in premenopausal women with germline TP53 pathogenic variants (mTP53) (Li Fraumeni syndrome - LFS)…”
Get full text

Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: Evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO by Coelho Cerqueira, Eduardo, Netz, Paulo Augusto, Diniz, Cristiane, Petry do Canto, Vanessa, Follmer, Cristian

“…Monoamine oxidase (MAO) catalyzes the oxidative deamination of biogenic and exogenous amines and its inhibitors have therapeutic value for several conditions…”
Get full text

Patterns of genetic diversity, spatial genetic structure and gene flow in Campomanesia xanthocarpa: insights from SSR markers of different genomic origins by PETRY, VANESSA S., STEFENON, VALDIR M., MACHADO, LILIAN O., COSTA, NEWTON C.F. DA, KLABUNDE, GUSTAVO H.F., NODARI, RUBENS O.

“…Abstract Campomanesia xanthocarpa (Mart.) O. Berg is a South American fruit tree species with important ecological and medicinal properties, which remnants are…”
Get full text

Influence of a Training Session on Postural Stability and Foot Loading Patterns in Soccer Players by Petry, Vanessa K N, Paletta, Jürgen R J, El-Zayat, Bilal F, Efe, Turgay, Michel, Nathalie S D, Skwara, Adrian

“…Sport specific movements coming along with characteristic plantar pressure distribution and a fatigue of muscles result in an increasing postural sway and…”
Get full text

Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis by Bessa, Giancarlo Rezende, Quinto, Vanessa Petry, Machado, Daiane Corrêa, Lipnharski, Caroline, Weber, Magda Blessmann, Bonamigo, Renan Rangel, D'Azevedo, Pedro Alves

“…Topical antimicrobial drugs are indicated for limited superficial pyodermitis treatment, although they are largely used as self-prescribed medication for a…”
Get full text

Abstract PS16-34: Phenotype and prognosis of patients with breast cancer and pathogenic TP53 variants by Petry, Vanessa

“…Background: The lifetime risk of cancer in individuals with Li Fraumeni syndrome (LFS) is more than 70% for men and more than 90% for women. Breast cancer (BC)…”
Get full text

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy by Arai, Roberto J, Petry, Vanessa, Hoff, Paulo M, Mano, Max S

“…Metronomic therapy has been gaining importance in the neoadjuvant setting of breast cancer treatment. Its clinical benefits may involve antiangiogenic…”
Get full text

Repetitive genomic elements in Campomanesia xanthocarpa: prospection, characterization and cross amplification of molecular markers by Petry, Vanessa S., Stefenon, Valdir Marcos, Machado, Lilian O., Klabunde, Gustavo H. F., Pedrosa, Fábio O., Nodari, Rubens O.

“…Repetitive genomic elements were prospected in Campomanesia xanthocarpa , aiming to characterize these elements in a non-model plant species and to develop…”
Get full text

Colonization by S. Aureusincreases the EASI and the number of appointments by patients with atopic dermatitis: cohort with 93 patients by Lipnharski, Caroline, d'Azevedo, Pedro Alves, Quinto, Vanessa Petry, Bessa, Giancarlo, Bonamigo, Renan Rangel

“…BACKGROUND:Atopic dermatitis leads to epidermal barrier dysfunction and bacteria colonization. The relationship of the last factor with the severity of the…”
Get full text

Characterization of Phenotypic Diversity of Feijoa Fruits of Germplasm Accessions in Brazil by Sánchez‐Mora, Fernando David, Saifert, Luciano, Ciotta, Marlise Nara, Ribeiro, Humberto Nunes, Petry, Vanessa Samara, Rojas‐Molina, Anyela Mayerly, Lopes, Morgana Elis, Lombardi, Gregório Giampiccolo, Santos, Karine Louise, Ducroquet, Jean Pierre Henri Joseph, Nodari, Rubens Onofre

“…Core Ideas Feijoa fruit combine unique flavor and medicinal properties. The Brazilian feijoa collection exhibit high variability in fruit traits. Years was the…”
Get full text

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial by Hurvitz, Sara A, Hegg, Roberto, Chung, Wei-Pang, Im, Seock-Ah, Jacot, William, Ganju, Vinod, Chiu, Joanne Wing Yan, Xu, Binghe, Hamilton, Erika, Madhusudan, Srinivasan, Iwata, Hiroji, Altintas, Sevilay, Henning, Jan-Willem, Curigliano, Giuseppe, Perez-Garcia, José Manuel, Kim, Sung-Bae, Petry, Vanessa, Huang, Chiun-Sheng, Li, Wei, Frenel, Jean-Sebastien, Antolin, Silvia, Yeo, Winnie, Bianchini, Giampaolo, Loi, Sherene, Tsurutani, Junji, Egorov, Anton, Liu, Yali, Cathcart, Jillian, Ashfaque, Shahid, Cortés, Javier

“…An improvement in progression-free survival was shown with trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast…”
Get full text

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer by Cortés, Javier, Kim, Sung-Bae, Chung, Wei-Pang, Im, Seock-Ah, Park, Yeon Hee, Hegg, Roberto, Kim, Min Hwan, Tseng, Ling-Ming, Petry, Vanessa, Chung, Chi-Feng, Iwata, Hiroji, Hamilton, Erika, Curigliano, Giuseppe, Xu, Binghe, Huang, Chiun-Sheng, Kim, Jee Hyun, Chiu, Joanne W.Y, Pedrini, Jose Luiz, Lee, Caleb, Liu, Yali, Cathcart, Jillian, Bako, Emarjola, Verma, Sunil, Hurvitz, Sara A

“…In patients with metastatic HER2-positive breast cancer that had progressed after primary therapy, treatment with the antibody–drug conjugate trastuzumab…”
Get full text

Polyurethanases: Three-dimensional structures and molecular dynamics simulations of enzymes that degrade polyurethane by do Canto, Vanessa Petry, Thompson, Claudia Elizabeth, Netz, Paulo Augusto

“…The global production of plastics increases every year, because these materials are widely used in several segments of modern life. Polyurethanes are a very…”
Get full text

Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience by Gomes da Fonseca, Leonardo, de Melo Gagliato, Debora, Takahashi, Tiago K., Perez Mak, Milena, Barroso-Sousa, Romualdo, Testa, Laura, Petry Helena, Vanessa, de Paula Costa, Romulo, Hoff, Paulo M., Mano, Max S.

“…Background: Trastuzumab improves the survival of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). The incidence and…”
Get full text

Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique by Petry, Vanessa, Bonadio, Renata Colombo, Moutinho, Karina, Leite, Luiz Senna, Testa, Laura, Cohn, Daniela J. B. Heinemann, Cagnacci, Allyne Carneiro, Kim, Veronica E.H., Del Pilar Estevez-Diz, Maria, Fragoso, Maria Candida Barrisson Villares

“…Breast cancer (BC) is the most common malignancy in female patients with Li-Fraumeni syndrome (LFS), a condition associated with an increased risk of various…”
Get full text

Trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients (pts) with HER2-positive (HER2+) unresectable and/or metastatic breast cancer (mBC): Safety follow-up of the randomized, phase 3 study DESTINY-Breast03 by Hamilton, Erika P., Bragaia, Vanessa PETRY HELENA, Yeo, Winnie, Kim, Sung-Bae, Bianchini, Giampaolo, Yamashita, Toshinari, Yonemori, Kan, Inoue, Kenichi, Curigliano, Giuseppe, Hurvitz, Sara A., Cortes, Javier, Iwata, Hiroji, Cathcart, Jillian, Liu, Yali, Lee, Caleb C., Bako, Emarjola, Kim, Rachel, Im, Seock-Ah

“…1000 Background: In the DESTINY-Breast03 (NCT03529110) primary analysis (data cutoff [DCO], May 21, 2021), T-DXd showed superiority over T-DM1 in pts with…”
Get full text

Abstract GS3-01: Trastuzumab deruxtecan (T-DXd; DS-8201a) vs. trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (mBC): subgroup analyses from the randomized phase 3 study DESTINY-Breast03 by Hurvitz, Sara, Kim, Sung-Bae, Chung, Wei-Pang, Im, Seock-Ah, Park, Yeon Hee, Hegg, Roberto, Kim, Min-Hwan, Tseng, Ling-Ming, Petry, Vanessa, Chung, Chi-Feng, Iwata, Hiroji, Hamilton, Erika, Curigliano, Giuseppe, Xu, Binghe, Lee, Caleb, Liu, Yali, Cathcart, Jillian, Bako, Emarjola, Verma, Sunil, Cortés, Javier

“…Background: T-DXd is a HER2-targeting antibody-drug conjugate approved for the treatment of pts with advanced HER2+ mBC based on the DESTINY-Breast01 study…”
Get full text